BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Bryan Oronsky Scott Caroen Tony Reid |
| Publication date | August 11, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |